Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.
about
Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse modelThe 37kDa/67kDa laminin receptor acts as a receptor for Aβ42 internalization.High resolution imaging study of interactions between the 37 kDa/67 kDa laminin receptor and APP, beta-secretase and gamma-secretase in Alzheimer's disease.Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase ActivityAnti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicityAnti-LRP/LR specific antibody IgG1-iS18 significantly impedes adhesion and invasion in early and late stage colorectal carcinoma cells.Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.Novel patented therapeutic approaches targeting the 37/67 kDa laminin receptor for treatment of cancer and Alzheimer's disease.LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.The 37/67 kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67 kDa LR cell surface localization and interaction with the cellular prion protein.A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro.Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice.
P2860
Q28654400-5570B43B-E634-41EC-954A-BE405E607BB0Q33840258-3B5901BE-50BB-4FCC-88B9-5E2AB27FE79BQ35196471-DA4E66C8-EEB2-4342-AE1C-718D3DD7E670Q35834441-7FE9746A-6EC2-4756-92AA-6A3D2099A545Q37182136-46CF4B25-FB98-43F6-8006-5C526CA97864Q37370538-EBC03293-B835-45B1-BCC7-BCC32BB37484Q37596372-2B04C188-52C6-43FC-B59E-7DEF6F031033Q38369288-82234CEB-2848-4C6B-BBE4-15C4665FEA60Q38826444-6CD5BFEE-0F52-4E21-9547-87157E1E1A97Q39856446-9D2875A7-B78F-41F0-A347-CAAD9CD2B3E1Q41488632-927071FC-0639-4172-B0A5-C548E819F716Q46187627-2FFE2AB2-5976-4ACF-BB62-4665A9D56F21Q54956797-E9E292EA-42BD-4640-A97A-43672FB935E0Q55328599-EBCF3838-2ADC-41A1-8EFB-4F4421EFC1EF
P2860
Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-LRP/LR specific antibodie ...... edding in Alzheimer's disease.
@en
Anti-LRP/LR specific antibodie ...... edding in Alzheimer's disease.
@nl
type
label
Anti-LRP/LR specific antibodie ...... edding in Alzheimer's disease.
@en
Anti-LRP/LR specific antibodie ...... edding in Alzheimer's disease.
@nl
prefLabel
Anti-LRP/LR specific antibodie ...... edding in Alzheimer's disease.
@en
Anti-LRP/LR specific antibodie ...... edding in Alzheimer's disease.
@nl
P2093
P2860
P356
P1433
P1476
Anti-LRP/LR specific antibodie ...... edding in Alzheimer's disease.
@en
P2093
Bianca Da Costa Dias
Clement Penny
Danielle Gonsalves
Katarina Jovanovic
Kiashanee Moodley
Melvyn Little
Stefan F T Weiss
Stefan Knackmuss
Uwe Reusch
P2860
P2888
P356
10.1038/SREP02699
P407
P577
2013-01-01T00:00:00Z